20th Conference on Retroviruses and Opportunistic Infections (CROI) 3-6 March 2013, Atlanta
Featured
1 April 2013. Related: Conference reports , Conference index, CROI 20 (Retrovirus) 2013 Comment
Comment
HIV Treatment Bulletin
Conference reports
ARV pipeline: dolutegravir, TAF (GS-7340), MK-1439 and cenicriviroc
Featured
1 April 2013. Related: Antiretrovirals, Conference reports , CROI 20 (Retrovirus) 2013 Comment
ARV pipeline: long-acting formulations of rilpivirine, GSK-744 and nanoformulations
Featured
1 April 2013. Related: Antiretrovirals, Conference reports , CROI 20 (Retrovirus) 2013 Comment
Five-year results from the AntiRetroviral Research for Watoto (ARROW) Trial
Featured
1 April 2013. Related: Antiretrovirals, Conference reports, Paediatric care , CROI 20 (Retrovirus) 2013 Comment
Comparison of ritonavir-boosted lopinavir or NNRTI ART and PK with antimalarials in Ugandan children
1 April 2013. Related: Antiretrovirals, Conference reports, Paediatric care , CROI 20 (Retrovirus) 2013 Comment
Pharmacokinetics and acceptability of lopinavir/ritonavir sprinkles in children aged 1 to 4 years
1 April 2013. Related: Antiretrovirals, Conference reports, Paediatric care, PK and drug interactions , CROI 20 (Retrovirus) 2013 Comment
Pharmacokinetics of currently available antiretroviral options for young children
1 April 2013. Related: Antiretrovirals, Conference reports, Paediatric care, PK and drug interactions , CROI 20 (Retrovirus) 2013 Comment
Safety of transplacental raltegravir in neonates and washout pharmacokinetics
1 April 2013. Related: Antiretrovirals, Conference reports, PK and drug interactions, PMTCT and maternal health , CROI 20 (Retrovirus) 2013 Comment
Tenofovir use in children
1 April 2013. Related: Antiretrovirals, Conference reports, Paediatric care , CROI 20 (Retrovirus) 2013 Comment
ddI resistance in South African children failing an abacavir or d4T based first-line regimen
1 April 2013. Related: Antiretrovirals, Conference reports, Paediatric care, Resistance , CROI 20 (Retrovirus) 2013 Comment
Statin use in HIV positive people
1 April 2013. Related: Conference reports, Side effects , CROI 20 (Retrovirus) 2013 Comment
RIFAQUIN study demonstrates once-weekly dosing during follow-up phase of TB treatment
1 April 2013. Related: Conference reports, Opportunistic infections and complications, TB coinfection , CROI 20 (Retrovirus) 2013 Comment
Combining Xpert and LAM urine testing improves TB diagnostic sensitivity
1 April 2013. Related: Conference reports, Diagnostics, Opportunistic infections and complications, TB coinfection , CROI 20 (Retrovirus) 2013 Comment
Deferring ART by four weeks reduces mortality in patients diagnosed with cryptococcal meningitis
1 April 2013. Related: Conference reports, Opportunistic infections and complications , CROI 20 (Retrovirus) 2013 Comment
Monthly injection protects macaques from rectal exposure: results should fast-track human studies for advanced PrEP options
1 April 2013. Related: Conference reports, Transmission and prevention , CROI 20 (Retrovirus) 2013 Comment
Tenofovir DF ring protects macaques from vaginal exposure
1 April 2013. Related: Conference reports, Transmission and prevention , CROI 20 (Retrovirus) 2013 Comment
VOICE study reports low adherence as reason for lack of efficacy for PrEP: anal sex common in African heterosexuals
1 April 2013. Related: Conference reports, Transmission and prevention , CROI 20 (Retrovirus) 2013 Comment
Further studies on how male circumcision may reduce HIV transmission
1 April 2013. Related: Conference reports, Transmission and prevention , CROI 20 (Retrovirus) 2013 Comment
Report of a functional cure in an HIV infected infant
1 April 2013. Related: Conference reports, Cure research, Paediatric care , CROI 20 (Retrovirus) 2013 Comment
3rd International Workshop on HIV and Women, 14-15 January 2013, Toronto
1 February 2013. Related: Conference reports , Conference index, Intl Workshop on HIV and Women 3rd 2013
Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness
1 February 2013. Related: Antiretrovirals, Conference reports, Women's health , Intl Workshop on HIV and Women 3rd 2013
Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Transmission and prevention, Women's health , Intl Workshop on HIV and Women 3rd 2013
Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA
1 February 2013. Related: Antiretrovirals, Conference reports, Women's health , Intl Workshop on HIV and Women 3rd 2013
Lopinavir/ritonavir in pregnancy: results from a systematic review
1 February 2013. Related: Antiretrovirals, Conference reports, PMTCT and maternal health, Women's health , Intl Workshop on HIV and Women 3rd 2013
Possible mechanisms for adverse pregnancy outcomes in HIV positive women
1 February 2013. Related: Conference reports, PMTCT and maternal health, Women's health , Intl Workshop on HIV and Women 3rd 2013
43rd Union World Conference on Lung Health, 13-17 November 2012, Kuala Lumpur, Malaysia.
1 February 2013. Related: Conference reports , Conference index, World Conference on Lung Health 43rd 2013
Paediatric TB: glimpses of PK data and a potential new approach to drug development
1 February 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection , World Conference on Lung Health 43rd 2013
11th International Congress on Drug Therapy in HIV, 11-15 November 2012, Glasgow
1 December 2012. Related: Conference reports , Conference index, HIV 11 Glasgow 2012
Issues that divide expert opinion: when to start, HIV and ageing and the impact of HIV on life expectancy
1 December 2012. Related: Ageing and life expectancy, Conference reports , HIV 11 Glasgow 2012
Dolutegravir: integrase resistance and the impact of the background regimen
1 December 2012. Related: Antiretrovirals, Conference reports , HIV 11 Glasgow 2012
Updated results on Quad: 96 week data from phase 3 studies
1 December 2012. Related: Antiretrovirals, Conference reports , HIV 11 Glasgow 2012
HIV/HCV coinfection: early glimpses of an interferon-free future and EuroSIDA incidence data
1 December 2012. Related: Conference reports, Hepatitis coinfection , HIV 11 Glasgow 2012
Resistance in infants and children receiving ART in South Africa
1 December 2012. Related: Conference reports, Paediatric care , HIV 11 Glasgow 2012
63rd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), 9-13 November 2012, Boston
1 December 2012. Related: Conference reports , 63rd AASLD Boston 2012, Conference index
Cure rates with pipeline HCV drugs: reports from AASLD
1 December 2012. Related: Conference reports, Hepatitis coinfection , 63rd AASLD Boston 2012
3rd International Workshop on HIV and ageing, 5-6 November 2012, Baltimore
1 December 2012. Related: Conference reports , Conference index, HIV and Ageing Baltimore 2012
BHIVA Autumn Conference, 6-7 October 2012, London
1 December 2012. Related: Conference reports , BHIVA Autumn 2012, Conference index
52nd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 9-12 September 2012, San Francisco
1 October 2012. Related: Conference reports , Conference index, ICAAC 52nd San Francisco 2012
Study summaries from ICAAC 2012
1 October 2012. Related: Antiretrovirals, Basic science and immunology, Conference reports , ICAAC 52nd San Francisco 2012
Antiviral activity in vitro with S/GSK1265744
1 October 2012. Related: Antiretrovirals, Conference reports, Paediatric care , ICAAC 52nd San Francisco 2012
Efavirenz interaction studies with TB compounds bedaquiline and delamanid
1 October 2012. Related: Antiretrovirals, Conference reports, PK and drug interactions , ICAAC 52nd San Francisco 2012
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 October 2012. Related: Conference reports , Conference index, World AIDS 19 Washington 2012
HPTN-052: clinical advantages from earlier treatment
1 October 2012. Related: Antiretrovirals, Conference reports, Transmission and prevention , World AIDS 19 Washington 2012
Hormonal contraception and the risk of HIV acquisition
1 October 2012. Related: Conference reports, Women's health , World AIDS 19 Washington 2012
Towards an HIV cure: Early developments reported at IAS, part 2
1 October 2012. Related: Conference reports, Cure research , World AIDS 19 Washington 2012
Online video interviews between researchers and activists
1 October 2012. Related: Antiretrovirals, Conference reports, Cure research, Other news, Transmission and prevention, Treatment access , World AIDS 19 Washington 2012
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 August 2012. Related: Conference reports , Conference index, World AIDS 19 Washington 2012
IAS: social and political talks online as web casts
1 August 2012. Related: Conference reports, Treatment access, Treatment advocacy , World AIDS 19 Washington 2012
New booster – cobicistat as an alternative to ritonavir
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
Dolutegravir vs raltegravir in treatment-naive patients: 48 week results from the SPRING 2 study
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
Elvitegravir vs raltegravir: 96 week phase III results in treatment experienced patients
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
In vitro and animal data support safety profile BMS 986001: d4T-like NRTI currently in clinical trials
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
Switching to rilpivirine/tenofovir/FTC fixed dose combination from boosted-PI regimen: SPIRIT study draws the line at 24 weeks
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
Maraviroc plus atazanavir/ritonavir in a nuke-sparing regimen in treatment-naive patients
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
Five-year results from raltegravir registrational studies
1 August 2012. Related: Antiretrovirals, Conference reports , World AIDS 19 Washington 2012
First report: atazanavir-related gallstones (cholelithiasis)
1 August 2012. Related: Antiretrovirals, Conference reports, Side effects , World AIDS 19 Washington 2012
Paediatrics studies at 19th International AIDS Conference and the 4th International Workshop on HIV Pediatrics
1 August 2012. Related: Conference reports, Paediatric care , World AIDS 19 Washington 2012
Novel lopinavir/ritonavir sprinkle formulation for children in resource-limited settings
1 August 2012. Related: Antiretrovirals, Conference reports, Paediatric care , World AIDS 19 Washington 2012
Update on new antiretrovirals for children and adolescents
1 August 2012. Related: Antiretrovirals, Conference reports, Paediatric care , World AIDS 19 Washington 2012
Tenofovir prophylaxis for neonates
1 August 2012. Related: Conference reports, Paediatric care, PMTCT and maternal health , World AIDS 19 Washington 2012
Efavirenz levels variable in children in the CHAPAS-3 study
1 August 2012. Related: Antiretrovirals, Conference reports, Paediatric care , World AIDS 19 Washington 2012
Early initiation of ART is associated with growth recovery in children in NEVEREST-2
1 August 2012. Related: Antiretrovirals, Conference reports, Paediatric care , World AIDS 19 Washington 2012
High prevalence of peripheral neuropathy in children taking d4T in rural South Africa
1 August 2012. Related: Conference reports, Paediatric care, Side effects , World AIDS 19 Washington 2012
Lipid profile in children in PREDICT: immediate versus deferred nevirapine-based ART
1 August 2012. Related: Antiretrovirals, Conference reports, Paediatric care , World AIDS 19 Washington 2012
High levels of maraviroc in rectal tissue fail to protect macaques from SIV transmission following rectal exposure
1 August 2012. Related: Conference reports, Transmission and prevention , World AIDS 19 Washington 2012